You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

maintained on 2 mg or less of buprenorphine, in which discontinuation of agonist treatment is clinically feasible but difficult

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Critical Illness Trial in United Kingdom (Dexmedetomidine, Clonidine, Propofol)

Recruiting
  • Critical Illness
  • Belfast, United Kingdom
  • +43 more
Jan 19, 2023

Moderate to Severe Opioid Use Disorder Trial in Canada (Extended Release Subcutaneous Buprenorphine, Immediate Release

Not yet recruiting
  • Moderate to Severe Opioid Use Disorder
  • Extended Release Subcutaneous Buprenorphine
  • Immediate Release Sublingual Buprenorphine
  • Barrie, Ontario, Canada
  • +4 more
Oct 20, 2022

Opioid Dependence Fentanyl Trial in Harrisburg (Buprenorphine/naloxone)

Recruiting
  • Opioid Dependence Fentanyl
  • Harrisburg, Pennsylvania
    The Pennsylvania Psychiatric Institute
Dec 1, 2022

Endometriosis Trial (surveys (Fertiqol et SF36))

Not yet recruiting
  • Endometriosis
  • surveys (Fertiqol et SF36)
  • (no location specified)
Oct 26, 2023

Acute Pain, Analgesia Trial in Birmingham (Placebos, Baclofen 5 mg, Baclofen 10mg)

Recruiting
  • Acute Pain
  • Analgesia
  • Placebos
  • +2 more
  • Birmingham, Alabama
    University of Alabama, Birmingham
Dec 13, 2022

Analgesia, Abuse Opioids, Pain Trial in Nashville (Buccal Buprenorphine 300 mcg, Buccal Buprenorphine 600 mcg, Buccal

Not yet recruiting
  • Analgesia
  • +2 more
  • Buccal Buprenorphine 300 mcg
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Aug 8, 2023

Opioid-use Disorder Trial in New York (Vivitrol, Buprenorphine)

Completed
Has Results
  • Opioid-use Disorder
  • New York, New York
    New York State Psychiatric Institute
May 25, 2022

Substance Use Disorders Trial in Boston (Distress Tolerance - Benzodiazepine Discontinuation (DT-BD), BZD discontinuation

Completed
Has Results
  • Substance Use Disorders
  • Distress Tolerance - Benzodiazepine Discontinuation (DT-BD)
  • BZD discontinuation protocol
  • Boston, Massachusetts
    Boston Medical Center
Jan 20, 2022

Morbid Obesity, Metabolic Syndrome, Diabetes Trial in Columbia (GLP-1 receptor agonist)

Not yet recruiting
  • Morbid Obesity
  • +4 more
  • GLP-1 receptor agonist
  • Columbia, Missouri
    University of Missouri Hospital
Nov 20, 2023

Medication-Induced Dyskinesia Trial in Sweden (NLX-112, Placebo)

Recruiting
  • Medication-Induced Dyskinesia
  • Gothenburg, Sweden
  • +4 more
Nov 24, 2021

Respiratory Distress Syndrome Trial (Remazolam besylate, midazolam)

Not yet recruiting
  • Respiratory Distress Syndrome
  • (no location specified)
Feb 24, 2023

Opioid-use Disorder Trial in Edmonton, Vancouver (Buprenorphine/naloxone)

Recruiting
  • Opioid-use Disorder
  • Edmonton, Alberta, Canada
  • +3 more
Jul 30, 2021

Pain Trial in West Haven (Dronabinol, Placebos)

Recruiting
  • Pain
  • West Haven, Connecticut
    VA Healthcare System
Dec 21, 2022

Opioid Use Disorder Trial in Baltimore (Naloxone Nasal Spray)

Not yet recruiting
  • Opioid Use Disorder
  • Naloxone Nasal Spray
  • Baltimore, Maryland
    Johns Hopkins School of Medicine
Oct 13, 2023

Coronary Artery Disease, Dyslipidemias Trial in Yongin (a high dose of statin/ezetimib)

Recruiting
  • Coronary Artery Disease
  • Dyslipidemias
  • a high dose of statin/ezetimib
  • Yongin, Gyeonggi-do, Korea, Republic of
    Yongin Severance Hospital
Jun 14, 2023

Atrial Fibrillation, Peritoneal Dialysis Complication Trial (Anticoagulation Agents)

Not yet recruiting
  • Atrial Fibrillation
  • Peritoneal Dialysis Complication
  • Anticoagulation Agents
  • (no location specified)
Sep 13, 2023

Opioid Use Disorder Trial (Psilocybin)

Not yet recruiting
  • Opioid Use Disorder
  • (no location specified)
Oct 4, 2023

Inhalation Anesthesia, Dexmedetomidine, Sevoflurane Trial in Montréal (Dexmedetomidine, Placebo)

Not yet recruiting
  • Inhalation Anesthesia
  • +3 more
  • Montréal, Quebec, Canada
    Hôpital Maisonneuve-Rosemont, CIUSSS de l'Est de l'Ile de Montré
Nov 14, 2022

Osteoporosis Trial in Seoul (Zoledronic acid, once, Zoledronic acid, twice)

Recruiting
  • Osteoporosis
  • Zoledronic acid, once
  • Zoledronic acid, twice
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Apr 29, 2022

Cancer-Related Pain Trial in Philadelphia (Use of buprenorphine with FAO > 30 OME, CPM Rx application use)

Recruiting
  • Cancer-Related Pain
  • Use of buprenorphine with FAO > 30 OME
  • CPM Rx application use
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jun 9, 2023

Preeclampsia, Perinatal Haemorrhage Trial in Guangzhou (aspirin discontinuation, aspirin continuation)

Not yet recruiting
  • Preeclampsia
  • Perinatal Haemorrhage
  • aspirin discontinuation
  • aspirin continuation
  • Guangzhou, Guangdong, China
    FANG HE
Oct 26, 2023

Drug Dependence Trial in Little Rock (Gabapentin, Buprenorphine, Clonidine)

Completed
Has Results
  • Drug Dependence
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Jul 27, 2022

Opioid Use Disorder Trial in Roanoke (START NOW Group)

Completed
  • Opioid Use Disorder
  • START NOW Group
  • Roanoke, Virginia
    Carilion Clinic
Sep 20, 2022

Opioid-use Disorder Trial in New Haven (CBT4CBT-Buprenorphine, Buprenorphine/naloxone)

Completed
  • Opioid-use Disorder
  • New Haven, Connecticut
    Central Medical Unit of the APT Foundation
Jan 2, 2023

Opioid Use Disorder Trial (Psilocybin)

Not yet recruiting
  • Opioid Use Disorder
  • (no location specified)
Aug 17, 2023